NCT01114750View on ClinicalTrials.gov

A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

PHASE1SuspendedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

October 31, 2010

Conditions
Diabetes Mellitus
Interventions
DRUG

Insulin in dextran matrix capsule (and placebo)

Single dose capsule (and placebo)

Trial Locations (1)

Unknown

Karolinska Trial Alliance (KTA), Phase I Unit, Stockholm

Sponsors
All Listed Sponsors
lead

Bows Pharmaceuticals AG

INDUSTRY